e-learning
resources
Virtual 2020
Pre-Congress Content
Neonatal and paediatric intensive care: diagnosis, management and outcomes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Feasibility of less invasive surfactant administration (LISA) in the delivery suite
H. Ambulkar (London, United Kingdom), E. Williams (London, United Kingdom), A. Hickey (London, United Kingdom), R. Bhat (London, United Kingdom), T. Dassios (London, United Kingdom), A. Greenough (London, United Kingdom)
Source:
Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Session:
Neonatal and paediatric intensive care: diagnosis, management and outcomes
Session type:
E-poster session
Number:
2821
Disease area:
Paediatric lung diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ambulkar (London, United Kingdom), E. Williams (London, United Kingdom), A. Hickey (London, United Kingdom), R. Bhat (London, United Kingdom), T. Dassios (London, United Kingdom), A. Greenough (London, United Kingdom). Feasibility of less invasive surfactant administration (LISA) in the delivery suite. 2821
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Retrospective review of patient logging system data from an adaptive aerosol delivery system used for the delivery of iloprost inhalation solution
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology
Source: Annual Congress 2009 - Respiratory disorders of the newborn
Year: 2009
Late Breaking Abstract - Less invasive surfactant administration (LISA) to preterm infants on high flow nasal cannula (nHFT).
Source: Virtual Congress 2021 – Respiratory disorders in neonatal and paediatric intensive care
Year: 2021
Effectiveness, safety and delivery of pulmonary rehabilitation
Source: Virtual Congress 2021 – Living with a new norm: providing quality care in the post-COVID era
Year: 2021
Macro and microscopic evaluation of paclitaxel delivery in the airway with a novel endobronchial injectable drug delivery catheter
Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more
Year: 2013
In vitro
characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performance
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
Aerosol delivery
Source: Annual Congress 2013 –PG4 How to build an experimental animal lung lab
Year: 2013
Enhancing implementation, use, and delivery of pulmonary rehabilitation
Source: Guideline 2015
Year: 2015
Assessment of two different methods of bronchodilators delivery during noninvasive ventilation. Experimental in vivo approach
Source: Eur Respir J 2004; 24: Suppl. 48, 315s
Year: 2004
Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children
Source: Eur Respir J 2003; 21: 1007-1011
Year: 2003
Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Effect of different connections on aerosol delivery during non-invasive mechanical ventilation.
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020
Comparison of aerosol delivery from two inhaler technique-guidance devices.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Bench performance and lung deposition of the I-neb adaptive aerosol delivery system
Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies
Year: 2007
Incremental midazolam versus midazolame/rentanyl sedation during flexible bronchoscopy. Safety and tolerance in relation to the complexity of intervention
Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy
Year: 2012
Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM)
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Year: 2007
In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept